Global Neuroprosthetics Market, By Type (Output Neural Prosthetics and Input Neural Prosthetics), Technique (Deep Brain Stimulation, Vagus Nerve Stimulation, Spinal Cord Stimulation and Sacral Nerve Stimulation), Application (Motor Neuron Disorders, Physiological Disorders, and Cognitive Disorders), End User (Hospitals and Clinics) – Industry Trends and Forecast to 2031.
Neuroprosthetics Market Analysis and Size
The neuroprosthetics market is advancing with cutting-edge technologies such as brain-machine interfaces and neural implants. These innovations aim to restore motor functions and sensory perception in patients with neurological disorders. With increasing investments in research and development, coupled with rising demand for improved quality-of-life solutions, the market is poised for substantial growth in the coming years.
The global neuroprosthetics market size was valued at USD 24.03 billion in 2023 and is projected to reach USD 69.03 billion by 2031, with a CAGR of 14.1% during the forecast period of 2024 to 2031. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2024 to 2031
|
|
Base Year
|
2023
|
|
Historic Years
|
2022 (Customizable to 2016-2021)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Type (Output Neural Prosthetics and Input Neural Prosthetics), Technique (Deep Brain Stimulation, Vagus Nerve Stimulation, Spinal Cord Stimulation and Sacral Nerve Stimulation), Application (Motor Neuron Disorders, Physiological Disorders, and Cognitive Disorders), End User (Hospitals and Clinics)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
|
Market Players Covered
|
Boston Scientific Corporation (U.S.), Zimmer Biomet (U.S.), Cochlear Ltd. (Australia), Medtronic (U.S.), NDI Medical, LLC (U.S.), NeuroPace, Inc. (U.S.), NEVRO CORP (U.S.), Abbott (U.S.), Sonova (Switzerland), CorTec GmbH (Germany), Neuro Device Group S.A. (Poland), LivaNova PLC (U.K.), and MED-EL Medical Electronics (Austria)
|
|
Market Opportunities
|
|
Market Definition
Neuroprosthetics involves the development and application of devices that interface with the nervous system to restore lost sensory or motor functions. These devices can range from brain implants to artificial limbs, aiming to enhance the quality of life for individuals with disabilities. By bridging the gap between biology and technology, neuroprosthetics enables direct communication between the brain and external devices, offering promising avenues for rehabilitation and functional restoration.
Neuroprosthetics Market Dynamics
Drivers
- Rising Prevalence of Neurological Disorders
The rising prevalence of neurological disorders such as Parkinson's disease and epilepsy has significantly expanded the patient base seeking neuroprosthetic solutions. For instance, Parkinson's disease affects over 10 million people worldwide, driving demand for deep brain stimulation devices that mitigate symptoms. This trend fuels innovation and investment in neuroprosthetics, aiming to restore lost motor functions and improve the quality of life for affected individuals, thereby propelling market growth in the neuroprosthetics sector.
- Increasing Acceptance of Brain-Computer Interfaces (BCIs)
The increasing acceptance of Brain-Computer Interfaces (BCIs) among paralyzed individuals for communication and control purposes is significantly expanding the neuroprosthetics market. For instance, developments in BCIs have enabled paralyzed patients to communicate through direct brain signals, enhancing their quality of life. This growing adoption showcases BCIs as transformative tools beyond motor function restoration, driving demand for advanced neuroprosthetic solutions that integrate seamlessly with neural interfaces.
Opportunities
- Advancements in Neural Interface Technology
Advancements in neural interface technology, including enhanced electrode designs and biocompatible materials, are pivotal in driving the neuroprosthetics market. For instance, flexible and micro-scale electrodes improve neural signal detection accuracy and reduce tissue damage, extending device longevity. These innovations enable more precise control and functionality in neuroprosthetic devices, fostering opportunities for developing sophisticated solutions that cater to diverse neurological conditions, thereby expanding the market's potential and application scope.
- Rising Demand for Minimally Invasive Procedures
The rising demand for minimally invasive procedures is catalyzing innovation in neuroprosthetics, fostering the development of less invasive implantation techniques and devices. For instance, advancements in surgical robotics have enabled precise, minimally invasive implantation of neural interfaces, reducing recovery times and complications for patients. This trend not only enhances patient outcomes but also expands market opportunities by appealing to healthcare providers and patients seeking safer and more effective treatment options in neuroprosthetics.
Restraints/Challenges
- Limited Long-term Durability and Reliability
The neuroprosthetics market faces significant challenges in maintaining long-term functionality and durability. Issues such as material degradation, neural adaptation, and mechanical wear contribute to reduced device lifespan, necessitating frequent maintenance or replacement. These factors escalate costs and inconvenience for patients, thereby hindering market growth and adoption. Addressing these durability concerns is crucial to overcoming barriers to the widespread acceptance and use of neuroprosthetic technologies.
- Integration and Compatibility Issues
Integration and compatibility issues in neuroprosthetic devices hinder market growth due to complexities in aligning with diverse patient anatomies and physiological nuances. Challenges include minimizing tissue damage, optimizing long-term performance, and mitigating adverse effects, which collectively impede seamless integration into neural structures. These technical hurdles necessitate rigorous testing and customization efforts, contributing to delays in adoption and limiting widespread market acceptance.
This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Developments
- In December 2022, Saskatchewan's Ministry of Health and the Saskatchewan Health Authority launched an expanded Cochlear Implant Program, offering subsidized replacements for external sound processors. Individuals contribute USD 840 per implant, with the Ministry covering the remainder (USD 8,000 to USD 12,000). This initiative aims to enhance accessibility to auditory devices for those in need across the province
- In October 2022, Axoft, a neurotechnology firm, introduced a brain-machine interface (BMI) targeting neurological disorders. This FDA breakthrough device involves neural implants, with an initial USD 8 million in funding for FDA studies and prototype scaling. The innovation seeks to advance treatment efficacy and patient outcomes through advanced neurotechnology solutions
- In July 2021, Researchers at US San Francisco developed a groundbreaking "speech neuroprosthesis." This device enables individuals with severe paralysis to communicate in sentences by translating brain signals directly into spoken words displayed as text on a screen. The innovation represents a significant advancement in assistive technology, enhancing communication and quality of life for paralyzed individuals
- In April 2021, Houston Methodist and Rice University launched a collaborative center for Translational Neural Prosthetics. This partnership focuses on neuroprosthetics research aimed at restoring brain function post-disease or injury. The initiative integrates clinical expertise from Houston Methodist with research capabilities from Rice University, aiming to accelerate innovations in neural prosthetics for neurological rehabilitation
Neuroprosthetics Market Scope
The market is segmented on the basis of type, technique, application and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Output Neural Prosthetics
- Cognitive Prosthetics
- Motor Prosthetics
- Input Neural Prosthetics
- Cochlear Implant
- Visual Prosthetics
Technique
- Deep Brain Stimulation
- Vagus Nerve Stimulation
- Spinal Cord Stimulation
- Sacral Nerve Stimulation
Application
- Motor Neuron Disorders
- Parkinson's disease
- Epilepsy
- Physiological Disorders
- Auditory Disorders
- Ophthalmic Disorders
- Neurocardiac Disorders
- Over Active Bladder Syndrome
- Cognitive Disorders
- Alzheimer's disease
- Severe Depression
- Paralysis
End User
- Hospitals
- Clinics
Neuroprosthetics Market Regional Analysis/Insights
The market is analysed and market size insights and trends are provided by country, type, technique, application and end user as referenced above.
The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America is expected to dominate the neuroprosthetics market due to robust government and private funding, alongside well-established healthcare facilities. These factors facilitate advanced research, development, and adoption of neuroprosthetic technologies, positioning the region at the forefront of innovation and market growth in the field.
Asia-Pacific is estimated to witness high growth in the neuroprosthetics market. This surge is driven by efforts to reduce manufacturing costs of implants, increased investments by industry players, and rising patient awareness. These factors collectively contribute to a promising outlook for advancements and adoption of neuroprosthetic technologies in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the market. The data is available for historic period 2016-2021.
Competitive Landscape and Neuroprosthetics Market Share Analysis
The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.
Some of the major players operating in the market are:
- Boston Scientific Corporation (U.S.)
- Zimmer Biomet (U.S.)
- Cochlear Ltd. (Australia)
- Medtronic (U.S.)
- NDI Medical, LLC (U.S.)
- NeuroPace, Inc. (U.S.)
- NEVRO CORP (U.S.)
- Abbott (U.S.)
- Sonova (Switzerland)
- CorTec GmbH (Germany)
- Neuro Device Group S.A. (Poland)
- LivaNova PLC (U.K.)
- MED-EL Medical Electronics (Austria)
SKU-